Next-generation booster vaccine candidate demonstrates potential to protect against COVID-19 variants of concern, including Omicron BA.1 and BA.2, with a favorable safety and tolerability profile
SPLASH also houses the tools’ calibration for epMotion, Eppendorf automated liquid handling workstations.
TAK-003 is currently undergoing regulatory review for potential licensure in both the European Union
New Director supports NASDAQ rule on diversity
Marinus has broadened inclusion criteria in the RAISE trial to allow for enrollment of patients previously treated with IV anesthesia.
The second phase of the orientation workshop is being organized to provide in-depth knowledge to the state officials on core building blocks of ABDM
C2i Genomics expands its global reach and brings the first whole-genome sequencing minimal residual disease test to India
Norliqva was approved by the FDA on February 24, 2022 and is now available through normal retail distribution.
These and many other questions gather worldwide experts of the pharmaceutical industry at the PHARMAP 2022 which takes place in Berlin, Germany on June, 20 - 21, 2022
Focussed campaigns for old age homes, schools/colleges, prisons, brick kilns to be taken up by States/UTs
Subscribe To Our Newsletter & Stay Updated
